Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer
Phase 1 Completed
52 enrolled
Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer
Phase 1 Completed
39 enrolled
A PHASE IB STUDY OF IMMUNOTHERAPY WITH EX VIVO PRE-ACTIVATED AND EXPANDED CB-NK CELLS IN COMBINATION WITH CETUXIMAB, IN COLORECTAL CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE (MRD)
Phase 1 Completed
15 enrolled
AMPLIFY-201
Phase 1 Completed
25 enrolled 15 charts
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Phase 1 Completed
23 enrolled
Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
Phase 1 Completed
11 enrolled
Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer
Phase 1 Completed
10 enrolled
A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors
Phase 1 Completed
38 enrolled
Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)
Phase 1 Completed
86 enrolled
Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer
Phase 1 Completed
38 enrolled
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
Phase 1 Completed
121 enrolled
Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab
Phase 1 Completed
9 enrolled
A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers
Phase 1 Completed
129 enrolled 32 charts
A Vaccine (PolyPEPI1018 Vaccine) and TAS-102 for the Treatment of Metastatic Colorectal Cancer
Phase 1 Completed
15 enrolled
Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery
Phase 1 Completed
26 enrolled
Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
Phase 1 Completed
Vaccine Therapy in Treating Patients With Metastatic Cancer
Phase 1 Completed
Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors
Phase 1 Completed
23 enrolled
Vaccine Therapy in Treating Patients With Metastatic Solid Tumors
Phase 1 Completed
65 enrolled
Trial of PalloV-CC in Colon Cancer
Phase 1 Completed
24 enrolled
CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
Phase 1 Completed
19 enrolled
AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)
Phase 1 Completed
50 enrolled
AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer
Phase 1 Completed
31 enrolled
AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
Phase 1 Completed
26 enrolled
Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)
Phase 1 Completed
15 enrolled
Combined Immunotherapy and Radiosurgery for Metastatic Colorectal Cancer
Phase 1 Completed
19 enrolled
Clinical Study to Compare the Pharmacokinetics and Safety of Ramucirumab Injection With Cyramza ® in Healthy Male Volunteers
Phase 1 Completed
88 enrolled
Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803
Phase 1 Completed
14 enrolled
CATRIPCA
Phase 1 Completed
54 enrolled
A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer (APM4566g)
Phase 1 Completed
9 enrolled
Propofol With Clonidine and Ketamine Throughout Colon Cancer Surgery
Phase 1 Completed
60 enrolled
Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases
Phase 1 Completed
21 enrolled
AlloMem
Phase 1 Completed
10 enrolled
A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)
Phase 1 Completed
283 enrolled
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma
Phase 1 Completed
53 enrolled
Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal Carcinoma
Phase 1 Completed
95 enrolled
Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer
Phase 1 Completed
52 enrolled
Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid Tumors
Phase 1 Completed
68 enrolled
Aquamin and Prevention of Colon Cancer
Phase 1 Completed
36 enrolled
Dose-Escalation Study in Advanced Colon Cancer Patients
Phase 1 Completed
60 enrolled
Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients
Phase 1 Completed
107 enrolled
A Study of ARRY-438162 (MEK162) in Patients With Advanced Cancer
Phase 1 Completed
93 enrolled
Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer
Phase 1 Completed
11 enrolled 18 charts
A Study of ASN007 in Patients With Advanced Solid Tumors
Phase 1 Completed
49 enrolled
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Phase 1 Completed
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
Phase 1 Completed
79 enrolled
ADCC
Phase 1 Completed
24 enrolled
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
Phase 1 Completed
AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer
Phase 1 Completed
10 enrolled
LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer
Phase 1 Completed
25 enrolled